Literature DB >> 1692024

The role of cytosolic and membrane factors in processing of the human beta-2 adrenergic receptor following translocation and glycosylation in a cell-free system.

B K Kobilka1.   

Abstract

The beta-2 adrenergic receptor has been proposed to have seven membrane-spanning domains. Expression of functional beta-2 adrenergic receptor was achieved in a heterologous cell-free system composed of rabbit reticulocyte lysate and microsomal membranes from Xenopus laevis oocytes. The functional state of the receptor protein can be determined by ligand-binding assays and by the ability of ligands to alter the susceptibility of the receptor to proteinase K digestion. The process by which functional receptor is made was studied. The receptor protein remains nonfunctional immediately following translocation and glycosylation, and additional processing steps are needed before the receptor is able to interact with ligands. These processing steps require intact microsomal membranes as well as several cytosolic factors including ATP and one or more high molecular mass (greater than 30 kDa) factors but do not require receptor glycosylation and are not inhibited by nonhydrolyzable GTP analogues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1692024

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  Structural features of heterotrimeric G-protein-coupled receptors and their modulatory proteins.

Authors:  H LeVine
Journal:  Mol Neurobiol       Date:  1999-04       Impact factor: 5.590

2.  Non-competitive antagonism of beta(2)-agonist-mediated cyclic AMP accumulation by ICI 118551 in BC3H1 cells endogenously expressing constitutively active beta(2)-adrenoceptors.

Authors:  H E Hopkinson; M L Latif; S J Hill
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

3.  The structural basis of G-protein-coupled receptor signaling (Nobel Lecture).

Authors:  Brian Kobilka
Journal:  Angew Chem Int Ed Engl       Date:  2013-05-06       Impact factor: 15.336

4.  Large collective motions regulate the functional properties of glutamate transporter trimers.

Authors:  Jie Jiang; Indira H Shrivastava; Spencer D Watts; Ivet Bahar; Susan G Amara
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-29       Impact factor: 11.205

5.  Reorientation of aquaporin-1 topology during maturation in the endoplasmic reticulum.

Authors:  Y Lu; I R Turnbull; A Bragin; K Carveth; A S Verkman; W R Skach
Journal:  Mol Biol Cell       Date:  2000-09       Impact factor: 4.138

6.  C-X-C Motif Chemokine Receptor 3 Splice Variants Differentially Activate Beta-Arrestins to Regulate Downstream Signaling Pathways.

Authors:  Jeffrey S Smith; Priya Alagesan; Nimit K Desai; Thomas F Pack; Jiao-Hui Wu; Asuka Inoue; Neil J Freedman; Sudarshan Rajagopal
Journal:  Mol Pharmacol       Date:  2017-05-30       Impact factor: 4.436

7.  Significance of the carbohydrate moiety of the rat ovarian luteinizing-hormone/chorionic-gonadotropin receptor for ligand-binding specificity and signal transduction.

Authors:  U E Petäjä-Repo; W E Merz; H J Rajaniemi
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

8.  Complementation of formyl peptide receptor-mediated signal transduction in Xenopus laevis oocytes.

Authors:  P Schultz; P Stannek; M Voigt; K H Jakobs; P Gierschik
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

9.  Multiresidue Method for Analysis of β Agonists in Swine Urine by Enzyme Linked Receptor Assay Based on β2 Adrenergic Receptor Expressed in HEK293 Cells.

Authors:  Jian Wang; Yongxin She; Miao Wang; Maojun Jin; Yongfei Li; Jing Wang; Yuan Liu
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

Review 10.  Easy Synthesis of Complex Biomolecular Assemblies: Wheat Germ Cell-Free Protein Expression in Structural Biology.

Authors:  Marie-Laure Fogeron; Lauriane Lecoq; Laura Cole; Matthias Harbers; Anja Böckmann
Journal:  Front Mol Biosci       Date:  2021-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.